hotel maksoud plaza são paulo sp brasil october 22 - 23, 2009
Transcrição
hotel maksoud plaza são paulo sp brasil october 22 - 23, 2009
HOTEL MAKSOUD PLAZA SÃO PAULO SP BRASIL OCTOBER 22 - 23, 2009 Organization With unrestricted educational grant from As the President of the Brazilian Society of Internal Medicine and the Brazilian Clinical Research Institute (BCRI) I am honored to welcome you to the 2nd. International Symposium of Thrombosis and Anticoagulation ISTA 2009. The main purpose of this symposium is to discuss the most recent evidence on thrombosis and anticoagulation, including new agents under development and novel diagnostic tools in the field. The focus is to understand how to better apply the evidence into clinical practice so that the patients will gain and you will enhance the quality of care you offer your patients. This meeting provides a unique opportunity to witness the latest knowledge in this field. The clinical aspects including the most update treatments are our major objective in order to offer you concise answers that will help in the patient management on a day-by-day basis. I Hope you enjoy this scientific program and take advantage of the presence of our expert national and international faculty. Antonio Carlos Lopes, MD, PhD, FACP Brazilian Society of Internal Medicine President Co-Chairs Becker, Richard C. MD Duke University (USA) Lopes, Renato D. MD, MHS, PhD Federal University of Sao Paulo (UNIFESP-EPM) Duke University (USA) International Faculty Alexander, John H. Duke University (USA) Garcia, David University of New Mexico (USA) Granger, Christopher B. Duke University (USA) Handller, Allison Duke University (USA) Jolicoeur, E. Marc Montreal Heart Institute (Canada) Newby, L. Kristin Duke University (USA) Pieper, Karen S. Duke University (USA) National Faculty Baruzzi, Antonio Claudio Carvalho, Antonio Carlos Chamone, Dalton de Alencar F. Guimarães, Hélio Penna Lopes, Antonio Carlos Machado, Fabio Santana Timerman, Ari Scientific Program OCTOBER 22, 2009 09:0009:10Opening Antonio Carlos Lopes, Richard C. Becker, and Renato D. Lopes SESSION I President: Christopher B. Granger 09:1009:30 Update in Thrombosis and Anticoagulation in Clinical Practice Richard C. Becker 09:4010:00 Biomarkers of Thrombosis - How and Which one to Use? L. Kristin Newby 10:1010:30 Anticoagulation in Acute Coronary Syndromes Ari Timerman 10:30 10:50 Coffee Break 10:5011:10 Triple Therapy - A Management Dilemma Renato D. Lopes 11:2011:40 Stroke: Should We use Antithrombotics? When and How? Fabio Santana Machado 11:4012:00 Challenging Cases David Garcia 12:0014:00Break SESSION II President: E. Marc Jolicoeur 14:0015:20 Thrombosis in: Diabetes: L. Kristin Newby Atrial Fibrillation: John H. Alexander Dyslipidemia: Christopher B. Granger Heart Failure/Hypertension: Antonio Carlos Carvalho 15:3015:50 Management of Bleeding Episodes in Patients receiving Antithrombotic Therapy David Garcia 16:00 16:30 Coffee Break 16:3017:00 Design Issues and Statistical Considerations around Clinical Research Karen Pieper 17:1017:40 Challenging Cases Renato D. Lopes / E. Marc Jolicoeur OCTOBER 23, 2009 SESSION III President: Antonio Carlos Lopes 09:0009:20 VTE prophilaxis in Medical Patients Renato D. Lopes 09:2509:55 Treatment for VTE Dalton de Alencar F. Chamone 10:0010:20 Post-thrombotic Syndrome: Epidemiology and Management Richard C. Becker 10:20 10:40 Coffee Break 10:4011:10 Predicting Cancer Patients at Risk for Venous Thromboembolism: Strategies for Prophylaxis David Garcia 11:1511:45 Diagnosis and Management of Pulmonary Embolism Antonio Claudio Baruzzi 11:5012:10 How to Better Interpret the Medical Literature? Karen Pieper 12:1512:45 Challenging Cases L. Kristin Newby 12:45 14:00Break SESSION IV 14:0014:20 14:3015:00 15:1015:30 15:40 16:00 16:0016:20 16:3016:50 17:0017:30 President: Christopher B. Granger Globalization of Clinical Research John H. Alexander Anticoagulation in Special Patient Populations E. Marc Jolicoeur Anticoagulation in Intensive Care Units Hélio Penna Guimarães Coffee Break The Latest ACCP Antithrombotic Therapy Guidelines: Important Changes that may Impact Clinical Practice David Garcia Importance of Academic Coordinating Center in Clinical Trials in Thrombosis Allison Handller Challenging Cases Renato D. Lopes / E. Marc Jolicoeur SBCM President and Co-Chairs Antonio Carlos Lopes, MD, PhD, FACP 4Full Professor of Internal Medicine, Federal University of São Paulo - Paulista School of Medicine 4Full Professor of Emergency Medicine, Federal University of São Paulo - Paulista School of Medicine 4PhD - Cardiology, Federal University of São Paulo Paulista School of Medicine 4President of the Brazilian Society of Internal Medicine 4President of the Brazilian Clinical Research Institute (BCRI) 4Fellow of the American College of Physicians Richard C. Becker, MD 4Professor of Medicine. Divisions of Cardiology and Hematology, Department of Medicine - Duke University Medical Center 4Director of the Duke Cardiovascular Thrombosis Center Duke Clinical Research Institute (DCRI) 4Co-director of the Advanced Biomarkers Program Duke Clinical Research Institute (DCRI) Renato Delascio Lopes MD, MHS, PhD 4Adjunct Professor - Division of Cardiology, Department of Medicine - Duke University Medical Center 4Assistant Director - Clinical Research Fellowship Program Duke Clinical Research Institute (DCRI) 4Assistant Professor - Department of Internal Medicine Federal University of Sao Paulo - Paulista School of Medicine 4Executive Director - Brazilian Clinical Research Institute (BCRI) Invited Speakers Christopher B. Granger, MD, FACC 4Professor of Medicine - Division of Cardiology, Department of Medicine - Duke University Medical Center 4Director, Cardiac Care Unit - Duke University Medical Center 4Co-Director of Cardiovascular Clinical Trials Duke Clinical Research Institute L. Kristin Newby, MD, MHS 4Associate Professor - Division of Cardiology, Department of Medicine - Duke University Medical Center 4Co-director of the Cardiac Care Unit Duke University Hospital 4Co-director of the Advanced Biomarkers Program Duke Clinical Research Institute (DCRI) John Alexander, MD, MHS, FACC 4Associate Professor - Division of Cardiology, Department of Medicine - Duke University Medical Center 4Director of Early Phase Cardiovascular Research Duke Clinical Research Institute (DCRI) 4Medical director of Site-Based Clinical Research in Cardiovascular Medicine Duke University Medical Center David Garcia, MD 4Associate Professor - Department of Internal Medicine Division of Hematology/Oncology University of New Mexico Health Sciences Center 4Director of Cancer and Thrombosis at the University of New Mexico Cancer Center - Director of the Anticoagulation Management Service at University Hospital Invited Speakers E. Marc Jolicœur, MD, MSc, FRCP 4Assistant Professor - Division of Cardiology, Department of Medicine - University of Montreal 4Research Associate, University of Montreal Karen S. Pieper, MS 4Associate Director for Faculty and Fellow Affairs and Clinical Trials Statistical Operations. Duke Clinical Research Institute (DCRI) Allison Handller RN, BSN, MS 4Senior Project Leader Cardiovascular Devices Phase III/IV Cardiovascular Mega trials Duke Clinical Rsearch Institute (DCRI) Antonio Carlos Carvalho, MD, PhD, FACC 4Full Professor of Cardiology, Federal University of São Paulo - Paulista School of Medicine 4PhD - Cardiology, Federal University of São Paulo - Paulista School of Medicine 4Scientific Director of the Brazilian Clinical Research Institute (BCRI) 4Fellow of the American College of Cardiology Dalton de Alencar Fischer Chamone, MD, PhD 4Full Professor of Hematology and Hemotherapy, São Paulo University Medical School 4PhD - Hematology and Hemottherapy, University of Louvain, Belgium 4Associate Professor, São Paulo University Pharmaceutical Sciences School Ari Timerman, MD, PhD 4Assistant Professor of Cardiology, ABC Foundation School of Medicine, 4PhD - Cardiology, São Paulo University Medical School 4Head of the Emergency and Intensive Therapy Division, Dante Pazzanese Institute of Cardiology 4President of the Cardiopulmonary Resuscitation Division of the Dante Pazzanese Institute of Cardiology 4Head Professor of the TIC5007, Cardiovascular Emergencies of the Postgraduate Program USP/IDPC Medicine/Technology and Intervention in Cardiology Antonio Claudio Baruzzi, MD, PhD 4PhD - Cardiology, Institute of the Heart, São Paulo University Medical School 4Physician of the Intensive Care Center, Albert Einstein Hospital Fabio Santana Machado, MD 4Medical Coordinator of the Neurosurgical ICU of the Neurosurgery, São Paulo University Medical School 4Collaborator Professor of the Internal Medicine, São Paulo University Medical School 4Physician of the Neuro-Intensive Care Unit, Sírio Libanês Hospital Hélio Penna Guimarães, MD 4Assistant Professor of Internal Medicine, Federal University of São Paulo - Paulista School of Medicine 4President of the Chapter of Emergency Medicine of the Brazilian Society of Internal Medicine 4Medical Coordinator, Teaching, Training and Simulation Center, Heart Hospital 4Financial Director of the Brazilian Clinical Research Institute (BCRI) Organization Support With unrestricted educational grant from Symposium Secretariat Caixa Postal: 19232 CEP: 04505 970 São Paulo SP + 55 11 3849 0379 Fax: + 55 11 3845 6818 www.meetingeventos.com.br [email protected]
Documentos relacionados
www.ista2012.com.br
strive to offer you practical answers that will help with patient management on a day-to-day basis. We hope you enjoy this scientific program and take advantage of the presence of our expert nation...
Leia maisENDO Pharmaceuticals
visual guide is enclosed for your use. If your patient does identify mixed-up tablets, they should promptly consult with you or their pharmacist. Pharmacists have been informed of this issue and ar...
Leia mais